Pharmaceuticals, Biotechnology and Life Sciences
Ernest E. Braxton Jr, MD, MBA, FAANS Dr. Ernest Braxton recently performed the first ASC outpatient robotic spine fusion case…
Greatest benefit continued to be seen in people who are at a high risk of recurrence (those with lymph node-positive…
IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports that on July 7, 2022 the…
ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) — Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets…
CLEVELAND, July 14, 2022 (GLOBE NEWSWIRE) — SPR Therapeutics announced today that two presentations highlighting SPRINT® PNS in treating chronic…
YONKERS, N.Y., July 13, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a biotechnology company focused on the discovery and…
– Company to focus internal efforts on wholly-owned next-generation conditionally activated therapeutics, including IFN alpha-2b cytokine and EpCAM-directed ADC, INDs…
— Overview of phase 2 study evaluating SYK inhibitor mivavotinib in patients with relapsed/refractory non-GCB (ABC) diffuse large B-cell lymphoma —…
L’ASSOMPTION, Québec, July 13, 2022 (GLOBE NEWSWIRE) — Terranueva Corporation (CSE: TEQ) (“Terranueva” or the “Corporation”) announces the closing of…
AUSTIN, Texas, July 13, 2022 (GLOBE NEWSWIRE) — via Investorwire — QSAM Biosciences Inc. (OTCQB: QSAM) (the “Company”), a company…